Guggenheim Capital LLC Fibrogen Inc Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$11.4 - $14.6 $12,631 - $16,176	-1,108 Reduced 5.12%	20,525 $267,000
Q2 2022 Aug 15, 2022	SELL	$7.94 - $12.96 $15,141 - $24,714	-1,907 Reduced 8.1%	21,633 $228,000
Q1 2022 May 16, 2022	BUY	$12.02 - $16.79 $14,460 - $20,198	1,203 Added 5.39%	23,540 $283,000
Q4 2021 Feb 14, 2022	BUY	$9.93 - $15.39 $7,060 - $10,942	711 Added 3.29%	22,337 $315,000
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $5,110 - $13,373	-502 Reduced 2.27%	21,626 $221,000
Q2 2021 Aug 13, 2021	BUY	$18.57 - $35.68 $18,792 - $36,108	1,012 Added 4.79%	22,128 $589,000
Q1 2021 May 13, 2021	BUY	$31.0 - $55.72 $312,170 - $561,100	10,070 Added 91.16%	21,116 $733,000
Q4 2020 Feb 16, 2021	SELL	$37.09 - $48.97 $1.6 Million - $2.11 Million	-43,021 Reduced 79.57%	11,046 $410,000
Q3 2020 Nov 13, 2020	SELL	$40.47 - $45.5 $603,650 - $678,678	-14,916 Reduced 21.62%	54,067 $2.22 Million
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $411,391 - $540,985	12,631 Added 22.41%	68,983 $2.8 Million
Q1 2020 Jun 02, 2020	SELL	$23.3 - $45.96 $257,651 - $508,225	-11,058 Reduced 16.4%	56,352 $1.96 Million
Q4 2019 Feb 14, 2020	BUY	$34.58 - $48.06 $208,413 - $289,657	6,027 Added 9.82%	67,410 $2.89 Million
Q3 2019 Nov 14, 2019	SELL	$36.98 - $48.45 $46,705 - $61,192	-1,263 Reduced 2.02%	61,383 $2.27 Million
Q2 2019 Aug 14, 2019	BUY	$35.13 - $55.53 $8,079 - $12,771	230 Added 0.37%	62,646 $2.83 Million
Q1 2019 May 15, 2019	SELL	$42.83 - $59.91 $83,689 - $117,064	-1,954 Reduced 3.04%	62,416 $3.39 Million
Q4 2018 Feb 14, 2019	SELL	$37.97 - $60.16 $346,666 - $549,260	-9,130 Reduced 12.42%	64,370 $2.98 Million
Q3 2018 Nov 14, 2018	BUY	$56.3 - $67.25 $112,937 - $134,903	2,006 Added 2.81%	73,500 $4.47 Million
Q2 2018 Aug 14, 2018	SELL	$44.9 - $64.95 $136,675 - $197,707	-3,044 Reduced 4.08%	71,494 $4.48 Million
Q1 2018 May 15, 2018	SELL	$45.35 - $61.65 $306,248 - $416,322	-6,753 Reduced 8.31%	74,538 $3.44 Million
Q4 2017 Feb 14, 2018	BUY	$41.95 - $60.1 $3 Million - $4.3 Million	71,525 Added 732.39%	81,291 $3.85 Million
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $326,184 - $526,387	9,766	9,766 $524,000

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account